David C. Marek
Chief Executive Officer at MYOVANT SCIENCES LTD.
Profile
Mr. David C.
Marek is a Chief Executive Officer at Myovant Sciences Ltd.
Mr. Marek was previously employed as a Chief Executive Officer & Director by Myovant Sciences, Inc., a Chief Commercial Officer by Axsome Therapeutics, Inc., an EVP-Consumer Services & Commercial Strategy by WebMD Health Corp., a Managing Director by Saatchi & Saatchi Healthcare Advertising, and a Vice President & General Manager-Neuroscience by Amgen, Inc. He received his undergraduate degree from Washington State University.
David C. Marek active positions
| Companies | Position | Start |
|---|---|---|
| MYOVANT SCIENCES LTD. | Chief Executive Officer | 2021-01-03 |
Former positions of David C. Marek
| Companies | Position | End |
|---|---|---|
Myovant Sciences, Inc.
 Myovant Sciences, Inc. Medical SpecialtiesHealth Technology Myovant Sciences, Inc. offers therapeutics for women's health and prostate cancer. The company is headquartered in New York, NY. | Chief Executive Officer | 2023-05-31 |
| AXSOME THERAPEUTICS, INC. | Corporate Officer/Principal | 2020-12-30 |
| AMGEN INC. | Corporate Officer/Principal | 2019-05-31 |
| WEBMD HEALTH CORP. | Corporate Officer/Principal | 2013-12-31 |
Saatchi & Saatchi Healthcare Advertising
 Saatchi & Saatchi Healthcare Advertising Advertising/Marketing ServicesCommercial Services Part of Publicis Healthcare Communications Group, Inc., Saatchi & Saatchi Healthcare Advertising provides advertising services. | Corporate Officer/Principal | 2010-12-31 |
Training of David C. Marek
| Washington State University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| AXSOME THERAPEUTICS, INC. | Health Technology |
| AMGEN INC. | Health Technology |
| Private companies | 4 |
|---|---|
WebMD Health Corp.
 WebMD Health Corp. Internet Software/ServicesTechnology Services WebMD Health Corp. engages in the provision of health information services. It serves physicians, health care professionals, employers, and health plans through public and private online portals, mobile platforms, and health-focused publications. The company is headquartered in New York, NY. | Technology Services |
Saatchi & Saatchi Healthcare Advertising
Saatchi & Saatchi Healthcare Advertising Advertising/Marketing ServicesCommercial Services Part of Publicis Healthcare Communications Group, Inc., Saatchi & Saatchi Healthcare Advertising provides advertising services. | Commercial Services |
Myovant Sciences, Inc.
Myovant Sciences, Inc. Medical SpecialtiesHealth Technology Myovant Sciences, Inc. offers therapeutics for women's health and prostate cancer. The company is headquartered in New York, NY. | Health Technology |
Myovant Sciences Ltd.
 Myovant Sciences Ltd. BiotechnologyHealth Technology Myovant Sciences Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapies for the treatment of women's health and endocrine diseases. It offers ORGOVYXTM, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist for the treatment of adult patients with advanced prostate cancer, and MYFEMBREE, which is taken for the management of heavy menstrual bleeding associated with uterine fibroids. The company was founded on February 2, 2016 and is headquartered in London, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- David C. Marek
